Insider trades

Douglas A. Treco, Director of Crispr Therapeutics CRSP, has filed 1 purchase and 2 sales on the open market. The latest trade was on 06/05.

Douglas A. Treco

Director
First filing
23/04/04
Trades
22 trades
Buys / sales
1 / 2
12-month net buying
No record
Last trade
06/05

Trading activity

Transactions

Trade type
Open-market buy25/08/0625/08/0820,000 sh$57.03$1,140,600+1000.0%
Open-market sale25/04/0225/04/038,819 sh$0.89$7,848.91−17.7%
Open-market sale24/04/0224/04/037,523 sh$6.94$52,209.62−26.7%